| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 2.70e-05 | 207 | 18 | 4 | GO:0043484 | |
| Domain | DUF846_euk | 4.67e-06 | 4 | 17 | 2 | IPR008564 | |
| Domain | DUF846 | 4.67e-06 | 4 | 17 | 2 | PF05832 | |
| Domain | HnRNP-L/PTB | 7.79e-06 | 5 | 17 | 2 | IPR006536 | |
| Domain | RRM_1 | 1.50e-02 | 208 | 17 | 2 | PF00076 | |
| Domain | RRM | 1.63e-02 | 217 | 17 | 2 | SM00360 | |
| Domain | RRM_dom | 1.77e-02 | 227 | 17 | 2 | IPR000504 | |
| Domain | RRM | 1.82e-02 | 230 | 17 | 2 | PS50102 | |
| Domain | - | 2.03e-02 | 244 | 17 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.26e-02 | 258 | 17 | 2 | IPR012677 | |
| Pubmed | Human polypyrimidine tract-binding protein interacts with mitochondrial tRNA(Thr) in the cytosol. | 2.53e-07 | 2 | 18 | 2 | 26657638 | |
| Pubmed | Expression of human nPTB is limited by extreme suboptimal codon content. | 7.59e-07 | 3 | 18 | 2 | 18335065 | |
| Pubmed | PTBP1 is required for embryonic development before gastrulation. | 2.53e-06 | 5 | 18 | 2 | 21423341 | |
| Pubmed | Polypyrimidine tract-binding proteins are essential for B cell development. | 2.53e-06 | 5 | 18 | 2 | 32081131 | |
| Pubmed | 5.80e-06 | 952 | 18 | 6 | 38569033 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 9.23e-06 | 582 | 18 | 5 | 20467437 | |
| Pubmed | 1.39e-05 | 11 | 18 | 2 | 15546612 | ||
| Pubmed | 3.42e-05 | 17 | 18 | 2 | 32155439 | ||
| Pubmed | 1.24e-04 | 32 | 18 | 2 | 36252997 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.50e-04 | 203 | 18 | 3 | 22083510 | |
| Pubmed | Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. | 1.95e-04 | 40 | 18 | 2 | 23825951 | |
| Pubmed | 3.06e-04 | 653 | 18 | 4 | 22586326 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 3.30e-04 | 52 | 18 | 2 | 24591637 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 4.00e-04 | 701 | 18 | 4 | 30196744 | |
| Pubmed | 4.49e-04 | 723 | 18 | 4 | 34133714 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 4.96e-04 | 1353 | 18 | 5 | 29467282 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 2.47e-03 | 189 | 18 | 2 | chr10q24 | |
| GeneFamily | RNA binding motif containing | 8.44e-03 | 213 | 12 | 2 | 725 | |
| Coexpression | AMIT_EGF_RESPONSE_240_MCF10A | 9.28e-05 | 21 | 18 | 2 | M2894 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | 1.46e-04 | 783 | 18 | 5 | M2488 | |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP | 1.80e-04 | 163 | 18 | 3 | M6329 | |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_DN | 2.32e-04 | 33 | 18 | 2 | M16114 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP | 3.09e-04 | 196 | 18 | 3 | M8970 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP | 3.23e-04 | 199 | 18 | 3 | M9491 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN | 3.23e-04 | 199 | 18 | 3 | M4670 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN | 3.23e-04 | 199 | 18 | 3 | M3107 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 3.28e-04 | 200 | 18 | 3 | M5980 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_UP | 3.28e-04 | 200 | 18 | 3 | M5162 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 3.28e-04 | 200 | 18 | 3 | M6480 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_DN | 3.42e-04 | 40 | 18 | 2 | M2169 | |
| Disease | lymphocyte:monocyte ratio | 5.65e-04 | 288 | 17 | 3 | EFO_0600088 | |
| Disease | Headache | 6.17e-04 | 64 | 17 | 2 | HP_0002315 | |
| Disease | Alzheimer disease, age at onset | 9.38e-04 | 343 | 17 | 3 | EFO_0004847, MONDO_0004975 | |
| Disease | social interaction measurement | 1.32e-03 | 94 | 17 | 2 | EFO_0009592 | |
| Disease | resting heart rate | 3.28e-03 | 149 | 17 | 2 | EFO_0004351 | |
| Disease | anthropometric measurement | 4.14e-03 | 168 | 17 | 2 | EFO_0004302 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.81e-03 | 200 | 17 | 2 | EFO_0004611, EFO_0020945 | |
| Disease | neutrophil count, eosinophil count | 6.57e-03 | 213 | 17 | 2 | EFO_0004833, EFO_0004842 | |
| Disease | neutrophil count, basophil count | 7.24e-03 | 224 | 17 | 2 | EFO_0004833, EFO_0005090 | |
| Disease | monocyte percentage of leukocytes | 7.95e-03 | 731 | 17 | 3 | EFO_0007989 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 8.20e-03 | 239 | 17 | 2 | EFO_0010934 | |
| Disease | granulocyte count | 9.22e-03 | 254 | 17 | 2 | EFO_0007987 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.07e-02 | 274 | 17 | 2 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.08e-02 | 276 | 17 | 2 | EFO_0004612, EFO_0020943 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKFSLFKSKKPRHRS | 5766 | Q09666 | |
| FPKRKKGEKRASSPF | 611 | Q14978 | |
| AKAKRAGKHRQPPAA | 66 | Q92585 | |
| FPKPGRVHHASEKKR | 286 | Q86V42 | |
| PKKPFRKLSRFGNAF | 121 | Q9H223 | |
| RPSKKDGFCFKLFHP | 201 | Q9BZF1 | |
| APKPRKKRSRAAFSH | 201 | P78367 | |
| GADKKFARKPPRFSC | 671 | Q92538 | |
| PEKFAKHKRFLGHSP | 1921 | Q05BV3 | |
| ARKEKKSPSGFHFHP | 926 | O94851 | |
| FGNSPLHRFKKPGSK | 431 | Q9UKA9 | |
| ARKSAAKHKFPGFPR | 266 | P34969 | |
| PRKAKIRHPVASFFH | 26 | Q96ET8 | |
| KRIPFGFKHRTLPHF | 796 | P24928 | |
| FSNSPLHRFKKPGSK | 451 | O95758 | |
| RGKKFDPDKSPFGHN | 296 | Q8TF39 | |
| PRKAKIRHPVASFFH | 26 | Q9NYZ1 | |
| AHFETRKLAGPKGRK | 491 | Q8N1T3 |